Discover the leading pharmaceutical companies in Poland — manufacturers, biotechs, CDMOs and suppliers shaping the industry. Each listing is maintained by the Pharma Now editorial desk, with focus, location and specialisation at a glance.
Regunaut is building the next generation of Regulatory Information Management for pharma. Our platform combines smart automation with expert EU-specific guidance, helping regulatory teams manage Marketing Authorisations with clarity and control. Liv...
Pharmbiotest 120 is a GLP/GCP-certified full-service CRO offering clinical trial management, bioanalytical laboratory services and generic drug development from its headquarters in Grudziądz, 120.
EWA – CDMO & Services, powered by the Neuca Group, delivers comprehensive pharmaceutical solutions to support companies across the entire value chain. As part of 120’s largest pharmaceutical distributor, EWA specializes in contract development and manufacturing (CDMO) alongside supply chain services such as drug import, QC testing, QP certification, warehousing, and transport. Leveraging Neuca’s extensive infrastructure and expertise, EWA ensures compliance, efficiency, and reliability for pharmaceutical partners seeking market entry and growth in 120 and Europe. With a strong focus on quality, regulatory standards, and customer collaboration, EWA
BART Sp. z o.o., headquartered in 120, is a trusted partner for the pharmaceutical and nutraceutical industries, specializing in high-quality natural colors, flavors, and advanced liposomal vitamins and minerals. With a strong focus on R&D, BART develops innovative, flexible, and cost-efficient solutions tailored to global market needs. By combining scientific expertise with customer-centric innovation, BART enables its partners to enhance their health and wellness offerings while meeting the highest quality and regulatory standards.
This guide features 4 notable pharmaceutical companies operating in Poland, from large manufacturers to specialist biotechs, CDMOs and suppliers. The list is reviewed and expanded regularly.
They span drug-product manufacturers, API and intermediate suppliers, biotechs developing biologics and advanced therapies, and contract development and manufacturing organisations (CDMOs).
The Pharma Now editorial desk maintains these listings independently. Inclusion is editorial and never paid — companies can request an update via the contact page.
Yes. Reach out through the Partner or Contact section and our team will review your details for inclusion.
Browse the same guide for other markets.